FGEN240517C7500
- 0.07
- 0.000.00%
FibroGen Newsroom
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday's session following weaker-than-expected quarterly results.Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of
FibroGen Shares Climb On Strong Q1 Sales
FibroGen, Inc. (NASDAQ:FGEN) shares are trading higher Tuesday after the company posted mixed first-quarter financial results. Here's a look at the key figures from the report. The Details:FibroGen re
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday.Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply during Tuesday's session following upbeat quarterly ear
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of Zeta Global Holdings Corp. (NASDAQ:ZETA) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and increased its second-q
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersFibroGen (NASDAQ:FGEN) shares rose 37.1% to $1.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $158.1 million. The company's, Q1 earnings came out yes
Top Premarket Gainers
Esperion Therapeutics (ESPR) shares surged more than 25% Tuesday premarket after the company posted improved Q1 financial results. FibroGen (FGEN) shares rose nearly 20% after the company reported a n
Trending Stocks Today: FibroGen Rises 17.24% Pre-Market
May 7th - US stocks trending pre-market: Gainers: $FibroGen(FGEN.US)$ gets a 17.24% boost to $1.36 with a turnover of $5.03 million. $Esperion Therapeutics(ESPR.US)$ soars 27.35% to $2.7 with a turnov
FibroGen to Participate in Upcoming Investor Conferences
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the company's management will participate in the following investor conferences: Bank of America He
FibroGen Shares Are Trading Higher After the Company Reported Mixed Q1 Financial Results.
FibroGen Shares Are Trading Higher After the Company Reported Mixed Q1 Financial Results.
Earnings Call Summary | FibroGen(FGEN.US) Q1 2024 Earnings Conference
The following is a summary of the FibroGen, Inc. (FGEN) Q1 2024 Earnings Call Transcript:Financial Performance:FibroGen recorded a Q1 2024 revenue of $55.9 million, a 55% increase from Q1 2023, driven
FibroGen Inc (FGEN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Goldman Sachs Remains a Sell on FibroGen (FGEN)
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAgape ATP (NASDAQ:ATPC) shares rose 23.0% to $0.32 during Monday's after-market session. The market value of their outstanding shares is at $24.9 million. FibroGen (NASDAQ:FGEN) shares increase
Express News | FibroGen Shares Are Trading Higher After the Company Reported Mixed Q1 Financial Results
FibroGen | 10-Q: Quarterly report
Express News | FibroGen Inc Shares up 18% at $1.37 After the Bell Following Results
Earnings Flash (FGEN) FIBROGEN Posts Q1 Revenue $55.9M, Vs. Street Est of $36.4M
04:11 PM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (FGEN) FIBROGEN Posts Q1 Revenue $55.9M, vs. Street Est of $36.4M
Express News | FibroGen Inc: Qtrly Total Revenue Was $55.9 Mln, as Compared to $36.2 Mln for Q1 of 2023
Express News | FibroGen Inc: Anticipate Filing of an Ind for FG-3175 (Anti-Ccr8 Mab) in 2025